series-a
Stage
5
Investors
About
ViAqua develops an oral delivery platform using RNA interference technology to improve disease resistance in aquaculture, specifically targeting viral diseases such as the White Spot Shrimp Virus through feed integration.
Explore ViAqua's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.